VITALE, Giovanni

	Titolo	Data di pubblicazione	Autore(i)
1	THE ROLE OF SEROTONIN BRAIN RECEPTORS IN THE ANALGESIC EFFECT OF PHENAZONE	1993	PINI LA; VITALE G; SANDRINI M
2	The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain	1999	M. Sandrini; G. Vitale; A. Ottani; LA Pini
3	The effect of Paracetamol on nociception and dynorphin A levels in the rat brain	2001	M. Sandrini; P. Romualdi; A. Capobianco; G. Vitale; G. Morelli; LA Pini; S. Candeletti
4	The effect of paracetamol and morphine combination on dynorphin A levels in the rat brain.	2001	M. Sandrini; P. Romualdi; G. Vitale; G. Morelli; A. Capobianco; LA Pini; S. Candeletti
5	The effect of chronic treatment with phenazone on [3H]-serotonin binding sites in pons and cortex membranes of the rat	1992	G. VITALE; L.A. PINI; M. SANDRINI
6	The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain	1996	LA Pini; M. Sandrini; G. Vitale
7	[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.	2012	Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G.
8	Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain	1997	M. Sandrini; G. Vitale; AV. Vergoni; A. Ottani; A. Bertolini
9	Serum levels of naltrexone and 6-beta-naltrexol after oral naltrexone in patients with liver cirrhosis	1993	Bertolotti M; Ferrari A; Vitale G; Trenti T; Loria P; Carulli N; Sternieri E.
10	Serotonin and opiate involvement in the antinociceptive effect of acetylsalicylic acid	1997	LA Pini; G. Vitale; M. Sandrini
11	Serotonergic and opiatergic modifications induced by paracetamol as a model for daily chronic headache with analgesic overuse	2004	Pini LA; Vitale G; Sandrini M
12	Plasma time-course of naltrexone and 6beta-naltrexol levels after oral administration in drug addicts and in patients with liver cirrhosis	1993	Bertolotti, M; Ferrari, A; Trenti, T; Vitale, G; Macchia, T; Carullin, ; Sternieri, E.
13	Plasma time-course of naltrexone and 6beta-naltrexol after oral naltrexone administration in patients with liver cirrhosis	1993	Bertolotti, Marco; Ferrari, Anna; Vitale, Giovanni; Trenti, T; Carulli, N; Sternieri, E.
14	Plasma reduced glutathione level and changes in thiol groups after glutathione administration in drug abuser patients -	1991	T. TRENTI; L. PAGLIANI; G. VITALE; L.A. PINI; B. BOTTI; V. VANNINI; E. STERNIERI
15	PHYSIOLOGICAL-PARAMETERS AND PLASMA-LEVELS AFTER SHORT AND LONG-TERM PROPOFOL INFUSION	1992	VITALE G; PINI LA; BERTELLINI E
16	Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet	2003	AFG Cicero; G. Vitale; G. Savino; R. Arletti
17	Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test	2005	M. Sandrini; G. Vitale; LA Pini; G. Lopetuso; P. Romualdi; S. Candeletti
18	Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation.	2013	Filaferro M; Novi C; Ruggieri V; Genedani S; Alboni S; Malagoli D; Caló G; Guerrini R; Vitale G.
19	Naltrexone: aspetti di farmacologia ed applicazioni cliniche	1994	Sternieri E; Ferrari A; Bertolotti M; Stefani M; Vitale G
20	Naltrexone and 6-Beta-naltrexol concentration/time profile in the treatment of opiate dependence	1994	Ferrari A ; Bertolotti M; Trenti T; Vitale G; Stefani M; Sternieri E